Cargando…

Serglycin Is Implicated in the Promotion of Aggressive Phenotype of Breast Cancer Cells

Serglycin is a proteoglycan expressed by some malignant cells. It promotes metastasis and protects some tumor cells from complement system attack. In the present study, we show for the first time the in situ expression of serglycin by breast cancer cells by immunohistochemistry in patients’ material...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korpetinou, Angeliki, Skandalis, Spyros S., Moustakas, Aristidis, Happonen, Kaisa E., Tveit, Heidi, Prydz, Kristian, Labropoulou, Vassiliki T., Giannopoulou, Efstathia, Kalofonos, Haralambos P., Blom, Anna M., Karamanos, Nikos K., Theocharis, Achilleas D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815026/ https://www.ncbi.nlm.nih.gov/pubmed/24205138 http://dx.doi.org/10.1371/journal.pone.0078157

Ejemplares similares

Serglycin: At the Crossroad of Inflammation and Malignancy
por: Korpetinou, Angeliki, et al.
Publicado: (2014)

Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines
por: Korpetinou, Angeliki, et al.
Publicado: (2015)

Expression of Syndecan-4 and Correlation with Metastatic Potential in Testicular Germ Cell Tumours
por: Labropoulou, Vassiliki T., et al.
Publicado: (2013)

Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential
por: Manou, Dimitra, et al.
Publicado: (2020)

Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas
por: Skandalis, Spyros S, et al.
Publicado: (2011)

IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules
por: Afratis, Nikolaos A., et al.
Publicado: (2017)

Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
por: Giannopoulou, Efstathia, et al.
Publicado: (2015)

Serglycin in human cancers
por: Li, Xin-Jian, et al.
Publicado: (2011)

Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway
por: Siatis, Konstantinos E., et al.
Publicado: (2023)

Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression
por: Roy, Ananya, et al.
Publicado: (2017)

Complexity of matrix phenotypes
por: Iozzo, Renato V., et al.
Publicado: (2020)

Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue
por: Tellez-Gabriel, Marta, et al.
Publicado: (2022)

Serglycin in Quiescent and Proliferating Primary Endothelial Cells
por: Reine, Trine M., et al.
Publicado: (2015)

The Exposure of Breast Cancer Cells to Fulvestrant and Tamoxifen Modulates Cell Migration Differently
por: Lymperatou, Dionysia, et al.
Publicado: (2013)

Serglycin is part of the secretory repertoire of LPS-activated monocytes
por: Kolseth, Ingrid Benedicte M, et al.
Publicado: (2015)

Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma
por: Roy, Ananya, et al.
Publicado: (2016)

Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin
por: Du, Xiaohuan, et al.
Publicado: (2022)

Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner
por: Guo, J-Y, et al.
Publicado: (2017)

Salicylate suppresses the oncogenic hyaluronan network in metastatic breast cancer cells
por: Karalis, Theodoros T., et al.
Publicado: (2020)

Serglycin proteoglycans limit enteropathy in Trichinella spiralis-infected mice
por: Roy, Ananya, et al.
Publicado: (2016)

Molecular Interactions Stabilizing the Promatrix Metalloprotease-9·Serglycin Heteromer
por: Dawadi, Rangita, et al.
Publicado: (2020)

The relationship between plasma serglycin levels and the diagnosis of diabetic retinopathy
por: Wang, Layi, et al.
Publicado: (2020)

Syndecans as Modulators and Potential Pharmacological Targets in Cancer Progression
por: Barbouri, Despoina, et al.
Publicado: (2014)

Adhesion strength and anti-tumor agents regulate vinculin of breast cancer cells
por: Metsiou, Despoina Nektaria, et al.
Publicado: (2022)

Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer
por: Zhu, Yun, et al.
Publicado: (2021)

Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone
por: He, Yunfei, et al.
Publicado: (2021)

Antiproliferative effect of exemestane in lung cancer cells
por: Koutras, Angelos, et al.
Publicado: (2009)

ADAMTS Expression in Colorectal Cancer
por: Filou, Serafula, et al.
Publicado: (2015)

Enhancement of mesenchymal stem cells’ chondrogenic potential by type II collagen-based bioscaffolds
por: Piperigkou, Zoi, et al.
Publicado: (2023)

Serglycin promotes proliferation, migration, and invasion via the JAK/STAT signaling pathway in osteosarcoma
por: Lv, Bin, et al.
Publicado: (2021)

The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle
por: Hjorth, Marit, et al.
Publicado: (2015)

Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes
por: Purushothaman, Anurag, et al.
Publicado: (2017)

miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin
por: Du, Qiwei, et al.
Publicado: (2021)

Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection
por: Lanara, Zoi, et al.
Publicado: (2013)

Glucose and Amino Acid Metabolic Dependencies Linked to Stemness and Metastasis in Different Aggressive Cancer Types
por: Chisari, Andrea, et al.
Publicado: (2021)

CD44 Intracellular Domain: A Long Tale of a Short Tail
por: Skandalis, Spyros S.
Publicado: (2023)

IL‐6 and IL‐17A degradation by mast cells is mediated by a serglycin:serine protease axis
por: Waern, Ida, et al.
Publicado: (2015)

Serglycin-Deficiency Causes Reduced Weight Gain and Changed Intestinal Cytokine Responses in Mice Infected With Giardia intestinalis
por: Li, Zhiqiang, et al.
Publicado: (2021)

Decellularised spinal cord matrix manipulates glial niche into repairing phase via serglycin‐mediated signalling pathway
por: Zhang, Sheng, et al.
Publicado: (2023)

The Notch and TGF-β Signaling Pathways Contribute to the Aggressiveness of Clear Cell Renal Cell Carcinoma
por: Sjölund, Jonas, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hc34qgjd87lu3vgejvv6bf9pbc